Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:FDFFNASDAQ:FMEDNASDAQ:HRTSNASDAQ:TARK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFDFFFidelity Disruptive Finance ETF$36.54-0.8%$36.21$29.09▼$39.78$47.50M1.424,858 shs11,014 shsFMEDFidelity Disruptive Medicine ETF$23.28-0.3%$23.42$20.69▼$26.79$48.89M1.035,750 shs2,878 shsHRTSTema GLP-1, Obesity & Cardiometabolic ETF$27.98-1.0%$27.96$25.32▼$36.03$53.16M0.939,815 shs3,247 shsTARKTradr 2X Long Innovation ETF$52.46+2.8%$35.54$18.25▼$61.52$118.56M5.56112,388 shs86,051 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFDFFFidelity Disruptive Finance ETF0.00%-2.70%-1.79%+4.36%+24.57%FMEDFidelity Disruptive Medicine ETF0.00%-2.36%-1.95%-4.71%-0.32%HRTSTema GLP-1, Obesity & Cardiometabolic ETF0.00%-3.15%+0.96%-5.70%-12.31%TARKTradr 2X Long Innovation ETF0.00%+15.22%+32.07%+51.62%+74.76%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFDFFFidelity Disruptive Finance ETFN/AN/AN/AN/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/AN/AN/AN/AN/AN/AN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/AN/AN/AN/AN/AN/AN/AN/ATARKTradr 2X Long Innovation ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFDFFFidelity Disruptive Finance ETF 2.68Moderate Buy$36.54N/AFMEDFidelity Disruptive Medicine ETF 2.84Moderate Buy$23.28N/AHRTSTema GLP-1, Obesity & Cardiometabolic ETF 2.76Moderate Buy$27.98N/ATARKTradr 2X Long Innovation ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFDFFFidelity Disruptive Finance ETFN/AN/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/AN/AN/AN/AN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/AN/AN/AN/AN/AN/ATARKTradr 2X Long Innovation ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFDFFFidelity Disruptive Finance ETFN/AN/A22.71∞N/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/A37.99∞N/AN/AN/AN/AN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/AN/A24.84∞N/AN/AN/AN/AN/ATARKTradr 2X Long Innovation ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFDFFFidelity Disruptive Finance ETF$0.260.71%N/AN/AN/AFMEDFidelity Disruptive Medicine ETF$0.110.47%N/AN/AN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETF$0.461.64%N/AN/AN/ATARKTradr 2X Long Innovation ETF$0.250.48%N/AN/AN/ALatest FMED, TARK, HRTS, and FDFF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/19/2025FDFFFidelity Disruptive Finance ETF$0.16106/20/20256/20/20256/24/20253/21/2025FDFFFidelity Disruptive Finance ETF$0.03503/21/20253/21/20253/25/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFDFFFidelity Disruptive Finance ETFN/AFMEDFidelity Disruptive Medicine ETFN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/ATARKTradr 2X Long Innovation ETFN/AInsider OwnershipCompanyInsider OwnershipFDFFFidelity Disruptive Finance ETFN/AFMEDFidelity Disruptive Medicine ETFN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/ATARKTradr 2X Long Innovation ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFDFFFidelity Disruptive Finance ETFN/A1.30 millionN/ANot OptionableFMEDFidelity Disruptive Medicine ETFN/A2.10 millionN/ANot OptionableHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/A1.90 millionN/AN/ATARKTradr 2X Long Innovation ETFN/A2.26 millionN/AOptionableFMED, TARK, HRTS, and FDFF HeadlinesRecent News About These CompaniesOptions Trading Now Available on Three Tradr ETFs: QBTX, TEMT and APPXMay 22, 2025 | standard-journal.comTop Performing Leveraged/Inverse ETFs: 05/18/2025May 21, 2025 | etftrends.comInvestment Managers Series Trust II - Tradr 2X Long Innovation 100 Quarterly ETFMay 21, 2025 | money.usnews.comInvestment Managers Series Trust II - Tradr 2X Long Innovation 100 Monthly ETFMay 21, 2025 | money.usnews.comMatt Mankiewicz on Tradr 2X Long QBTS Daily ETF (QBTX)May 20, 2025 | msn.comTop Performing Leveraged/Inverse ETFs: 03/23/2025March 26, 2025 | etftrends.comTop Performing Leveraged/Inverse ETFs: 12/08/2024December 11, 2024 | etftrends.comNovember Turns Out to Be the Best Month: 5 Top Leveraged ETFs (Revised)December 3, 2024 | zacks.comNovember Turns Out to Be the Best Month: 5 Top Leveraged ETFsDecember 2, 2024 | zacks.comTradr 2X Short Innovation Daily ETF (SARK)November 20, 2024 | finance.yahoo.comSPYQ Tradr 2X Long SPY Quarterly ETFNovember 15, 2024 | seekingalpha.comTop Performing Leveraged/Inverse ETFs: 11/10/2024November 13, 2024 | etftrends.comQQQP Tradr 2X Long Triple Q Quarterly ETFOctober 29, 2024 | seekingalpha.comQQQP Tradr 2X Long Triple Q Quarterly ETFOctober 29, 2024 | seekingalpha.comQQQW Tradr 2X Long Triple Q Weekly ETFOctober 25, 2024 | seekingalpha.comTradr 2X Long Triple Q Quarterly ETF (QQQP)October 23, 2024 | finance.yahoo.comTLTM Tradr 2X Long TLT Monthly ETFOctober 22, 2024 | seekingalpha.comTARK Tradr 2X Long Innovation ETFOctober 19, 2024 | seekingalpha.comTradr 2X Long Innovation ETF (NASDAQ:TARK), Short Interest ReportOctober 11, 2024 | benzinga.comTradr 2X Long SPY Quarterly ETF (SPYQ)October 10, 2024 | investing.comMedia Sentiment Over TimeFMED, TARK, HRTS, and FDFF Company DescriptionsFidelity Disruptive Finance ETF NASDAQ:FDFF$36.53 -0.31 (-0.83%) Closing price 03:38 PM EasternExtended Trading$36.53 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Fidelity Disruptive Finance ETF (FDFF) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that invests in disruptive finance companies. These are organizations in the finance industry that are pushing for innovative developments that may significantly alter the way they deliver their products and services FDFF was launched on Apr 16, 2020 and is managed by Fidelity.Fidelity Disruptive Medicine ETF NASDAQ:FMED$23.28 -0.06 (-0.26%) Closing price 03:58 PM EasternExtended Trading$23.28 -0.01 (-0.02%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.Tema GLP-1, Obesity & Cardiometabolic ETF NASDAQ:HRTS$27.98 -0.29 (-1.03%) As of 03:54 PM EasternThe Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.Tradr 2X Long Innovation ETF NASDAQ:TARK$52.46 +1.44 (+2.82%) Closing price 04:00 PM EasternExtended Trading$52.76 +0.30 (+0.56%) As of 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The AXS 2X Innovation ETF (TARK) is an exchange-traded fund that is based on the ARK Innovation ETF index. The fund is an actively-managed fund-of-fund that seeks to achieve 2x the return, for a single day, of the ARK Innovation ETF (ARKK) through swap agreements with major global financial institutions. TARK was launched on May 2, 2022 and is managed by AXS Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
